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(PHCCs) in Alexandria, Egypt regarding the use of drugs
using the WHO/INRUD drug use indicators: prescribing,
patient care and facility-specific indicators.
Subject and methods: One-thousand prescribing encounters
were investigated for a period from January to December
2010. Three-hundred patients and 10 pharmacists were
interviewed. Data entry and analysis were conducted using
SPSS version 19. Mean, median and SD were measured. An
ANOVA test was applied.
Results: Prescribing indicators were within optimal or
slightly below the optimal value except encounters with
antibiotics prescribed that were higher than the optimal
value. The difference between PHCCs was statistically sig-
nificant for all prescribing indicators (P= 0.000). Concern-
ing patient care indicators, average consultation and
dispensing times were short, and there was no drug labeling
at all. The difference between PHCCs was significant for all
patient care indicators except the percentage of drugs
labeled and patient’s knowledge of correct dosage. Both
facility-specific indicators were below the optimal value.
Conclusion: Prescribing indicators were below optimum
except average drugs/encounter and encounters with injec-
tion prescribed. Patient care indicators were below the opti-
mal level especially for average consultation dispensing
times and drug labeling. Facility-specific indicators were
below optimum.
Keywords: Primary health care; Rational; Use of drugs; WHO/
INRUD core drug use indicators
 2014 Taibah University. Production and hosting by Elsevier
Ltd. All rights reserved.
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and chronic diseases such as hypertension, diabetes, epilepsy
and mental disorders; waste of resources; increasing out-of-
pocket expenses to the patients; and adverse drug reactions.6
The increase of antibiotic resistance because of the over-use
of antibiotics is one of the problems under the irrational
use of medicines.6,9 Blood-borne diseases such as hepatitis,
and HIV/AIDS can be transmitted by the use of non-sterile
injections. Irrational use of medicines can result in patients
losing confidence in the health system.6,7,10 Also, about
one-third of the world’s population fails to take essential
medicines.6,7
WHO/INRUD (World Health Organization/International
Network of Rational Use of Drugs) developed drug use indi-
cators to be used as measures of performance in three general
areas related to the rational use of drugs in primary care. They
are called core drug use indicators.1
To researchers’ knowledge, no studies were performed in
Egypt measuring the use of drugs. Measured values could be
used as a benchmark among PHCC and as a baseline for fur-
ther follow-up of quality of drug use on an ongoing basis.
Objective
The objective was to measure the performance of (PHCCs)
regarding the use of drugs in Alexandria, Egypt using the
WHO/INRUD core drug use indicators namely:1
(1) Prescribing indicators: measure the performance of
health care providers in several key dimensions related
to the appropriate use of drugs.
 Average number of drugs per encounter.
 Percentage of drugs prescribed by generic name.
 Percentage of encounters with an antibiotic prescribed.
 Percentage of encounters with an injection
prescribed.
 Percentage of drugs prescribed from essential drugs
O.A. Akl et al. 55ntroduction
ppropriate use of drugs is one essential element in achieving
uality of health and medical care for patients and the commu-
ity as a whole.1
The World health organization (WHO) concluded that a
ational use of drugs requires that patients receive medications
ppropriate to their clinical needs, in doses that meet their own
ndividual requirements for an adequate period of time, and
he lowest cost to them and their community.2–5
Irrational use of medicines is a worldwide problem. There
re many ways that lead to an irrational use of medicines such
s patient usage of too many medicines (polypharmacy), inad-
quate dosage of antibiotics, use of antibiotics for non-bacte-
ial infections, over-use of injections when oral medication
an be more appropriate, prescribing the medicine that is inap-
ropriate to clinical guidelines and self-medication.6
Studies showed thatmore than 50%of allmedicinesworldwide
re incorrectly prescribed or sold and 50% of patients fail to use
hem.Arangebetween10%and20%of thenationalhealthbudget
developed countries vs 20% and 40% in developing countries is
pent inmedicines.6,7 Thus, the irrational use ofmedicines is an ex-
remely serious problem that needs to be solved.8
Irrational use of drugs can result in increasing the morbid-
ty and mortality rates especially in children with infections
list (EDL) or formulary.
(2) Patient care indicators: address key aspects of what
patients experience at health facilities, and how well they
have been prepared to deal with pharmaceuticals that
have been prescribed and dispensed.
 Average consultation time.
 Average dispensing time.
 Percentage of drugs actually dispensed.
 Percentage of drugs actually labeled.
 Patients’ knowledge of correct dosage.
(3) Facility-specific indicators: represent the features of the
working environment that measure the ability to pre-
scribe drugs rationally.
 Availability of a copy of the EDL or formulary.
 Availability of key drugs in the stock.
Material and Methods
Study design
Study design included a retrospective cohort study for pre-
scribing practice indicators and a cross-sectional study for pa-
tient care and facility specific indicators.
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Ten PHCCs from Alexandria were included. PHCCs were se-
lected based on a systematic random sampling representing the
eight districts of Alexandria, Egypt.
Target population, sample size, and data collection method
(a) Prescribing indicators: Medical records of patients
attending PHCCs/or prescription forms for the period
from January to December 2010 were the prescribing
indicators. A sample of 100 prescribing encounters/
PHCC were selected. Encounters were spread at regular
intervals throughout the year using systematic random
sampling to minimize the bias due to seasonal variations
or interruptions of the drug supply cycle. A total of
1000 prescribing encounters were included. Inclusion:
Encounters that took place during the period from
January to December 2010 were included. Referral or
vaccinations were excluded.
(b) Patient care indicators: Thirty patients who attended the
PHCC for diagnosis and treatment of general illnesses
representing a mix of health problems and age groups
were included in a cross-sectional survey. Patients
selected in the study were spread throughout the
clinic hour. They were observed and interviewed during
the survey visit to get the required variables. A total of
300 patients were interviewed using patient care form
(see Appendix). Inclusion: Patients included in the study
were those who attended PHCCs, were examined by
the physician, received treatment and were willing to
participate.
(c) Facility-specific indicators: Pharmacist from each PHCC
was interviewed during the survey visit. Ten pharmacists
were interviewed using a cross-sectional survey (facility
summary form) [see Appendix]. Inclusion: Pharmacists
of the PHCC under study were included.
Data collection tool
The blank examples of prescribing indicators form, patient
care form, and facility summary form were used to collect
the required variables.1 Data collection from the PHCC fol-
lowed the WHO guidelines and methodology to ensure reli-
ability of data collection.
Statistical analysis
Data entry and analysis were conducted using SPSS version 19.
Descriptive statistics were used in the form of mean, median, and
standard deviation. Differences between PHCCs were measured
using an ANOVA test. The statistical significance was determined
by a p value less than 0.05. To assess the rational drug use compre-
hensively, a new index was developed for each indicator, and then
Index ofRationalDrugPrescribing (IRDP), Index ofRational Pa-
tient-Care Drug Use (IRPCDU), and Index of Rational Facility-
Specific Drug Use (IRFSDU) were developed. Each of these indi-
ceswas developedbyapplying amathematicalmodel developedby
Zhang andZhi for a comprehensive appraisal ofmedical care. The
method has been validated and used in medical and health
research.11Theoptimal level for each indicator is shown inTable 3.
All the indicators have the same optimal index of 1: the closer to 1,
the more rational the drug use indicator. For IRDP, the index of
rational antibiotic prescribing was defined as dividing the optimal
level (630%)by the percentage of prescriptions including antibiot-
ics. The index of safety injection was calculated by dividing the
optimal level (610%) by the percentage of prescriptions including
injection.TheGeneric name indexwasmeasuredby thepercentage
of drugs prescribedby the generic name and sowas theEDL index.
The index of polypharmacy was measured by the percentage of
non-polypharmacy prescriptions. In this study, prescriptions with
threedrugsor lessweredefinedasnon-polypharmacy.The indexof
non-polypharmacy was measured by dividing average number of
drugs/encounter by 3.A total index (IRDP)was calculated by add-
ing up the previously mentioned indices. For IRPCDU, the index
of rational consultation time was defined as dividing the average
consultation time by the optimal level (P30 min). The index of ra-
tional dispensing time was calculated by dividing the average dis-
pensing time by the optimal level (P60 s).12 Index of drugs
adequately labeled was calculated as percentage of drugs labeled
with at least two items (patient name-drug dose-drug regimen). In-
dex of drugs actually dispensedwasmeasured by the percentage of
drugs actually dispensed and index of patients’ knowledge was cal-
culated by the percentage of patients who can adequately report
the dosage schedule for all drugs. A total index was calculated by
adding up the previously mentioned indices. For IRFSDU, the in-
dex of availability of copyofEDL/formularywas calculated by the
percentage of copy of EDL/formulary and so was the total index
calculated by adding up the previouslymentioned indices. A grand
total Index of Rational Drug Use (IRDU) was calculated by add-
ing up the total of IRDP, IRPCDU, and IRFSDU. Ranking of
PHCC was conducted based on these indices.
Ethical consideration
A formal approval from the Ministry of Health in Egypt was
taken before conducting the research. Confidentiality of the
data was considered.
Results
Drug prescribing indicators
The average number of drugs was 2.5 ± .8. The percentage of
drugs prescribed by the generic name was 95.4 ± 11.4. The
percentage of encounters with an antibiotic was 39.2 ± 8.8.
The percentage of encounters with an injection was 9.9 ± .9.
The percentage of drugs prescribed from EDL/formulary
was 95.4 ± 11.4 (Table 2). The difference between the PHCCs
was statistically significant for all prescribing indicators (Ta-
ble 1). Among PHCCs, Elmafrouza center represented the
highest rank for IRDP (Table 4 and Figure 1).
Patient care indicators
The average consultation time was 7.1 ± 2.2. The average dis-
pensing time was 47.4. The percentage of drugs actually dis-
pensed was 95.9 ± 20. The percentage of drugs adequately
labeled was 0 ± 0. The percentage of patients’ knowledge of
the correct dosage was 94 ± 23.8 (Table 2). The difference be-
Table 1: WHO/INRUD drug use indicators at Alexandria primary health care centers, Egypt (2010).
WHO/
INRUD
indicators/
PHCC
Smouha Sanstefano Eldeikhella Elaamreya Bor Elarab
New
Bor Elarab
Baheig
Elamrawy Elhaddara Elgomrok Elmafrouza ANOVA
Prescribing indicators
Average
drugs/
encounter
2.2 ± .8
2
2.0 ± .6
2
2.9 ± .8
3
3.1 ± .7
3
2.0 ± .5
2
2.3 ± .7
2
3.2 ± .7
3
2.7 ± .5
3
2.4 ± .8
3
2.1 ± .6
2
0.000
% drugs by
generic name
97.3 ± 9.5
100
98.6 ± 7.2
100
94.7 ± 11.8
100
88.7 ± 15.6
100
96.3 ± 9.9
100
96.4 ± 11.3
100
97.5 ± 8.8
100
95.3 ± 11.4
100
95.4 ± 11.8
100
93.8 ± 11.8
100
0.000
% encounters
with an
antibiotic
40.0 ± 49.2
0
39.0 ± 49.0
0
42.0 ± 49.6
0
27.0 ± 44.6
0
55.0 ± 50.0
100
25.0 ± 43.5
0
53.0 ± 50.2
100
38.0 ± 48.8
0
43.0 ± 49.8
0
30.0 ± 46.1
0
0.000
% encounters
with an
injection
5.0 ± 21.9
0
13.0 ± 33.8
0
7.0 ± 25.6
0
0.0 ± 0.0
0
22.0 ± 41.6
0
17.0 ± 37.8
0
9.0 ± 28.8
0
7.0 ± 25.6
0
12.0 ± 32.7
0
7.0 ± 25.6
0
0.000
% drugs from
EDL/
formulary
97.3 ± 9.5
100
98.6 ± 7.2
100
94.7 ± 11.8
100
88.2 ± 15.7
100
96.3 ± 9.9
100
96.4 ± 11.3
100
97.5 ± 8.8
100
95.3 ± 11.4
100
95.4 ± 11.8
100
93.8 ± 11.8
100
0.000
Patient care indicators
Average
consultation
time
8.1 ± 2.1
8
7.6 ± 2
8
6.1 ± 2
6
6.2 ± 2
6
7.4 ± 1.7
7
8 ± 1.4
8
5.2 ± 2.2
4.5
5.9 ± 1.8
6
8.3 ± 2.3
8
7.7 ± 1.9
8
0.000
Average
dispensing
time
49.2 ± 25.3
40
42.8 ± 19
40
45.8 ± 19
40
53.1 ± 13.3
52.50
38.0 ± 14
35
50.8 ± 22
42.50
52.3 ± 20
47.50
40 ± 7
40
57.3 ± 25.5
57.50
44.3 ± 20.6
40
0.001
% drugs
dispensed
96.7 ± 10.2
100
100 ± .0
100
90.6 ± 13.8
100
88.9 ± 14.1
100
96.7 ± 12.7
100
98. 9 ± 6.1
100
95 ± 10.2
100
98.3 ± 9.1
100
97.8 ± 8.5
100
96.7 ± 12.7
100
0.000
% drugs
labeled
0 ± 0
0
0 ± .0
0
0 ± 0
0
0 ± 0
0
0 ± 0
0
0 ± 0
0
0 ± 0
0
0 ± 0
0
0 ± 0
0
0 ± 0
0
0.440
Patients’
knowledge
93.3 ± 25.4
100
96.7 ± 18.3
100
96.7 ± 18.3
100
93.3 ± 25.4
100
96.7 ± 18.3
100
90 ± 30.5
100
86.7 ± 34.6
100
100 ± .0
100
96.7 ± 18.3
100
90 ± 30.5
100
0.537
Facility indicators
% copy of
EDL or
formulary
100
100
100
100
100
100
0
0
100
100
100
100
0
0
100
100
100
100
100
100
0.350
% key drugs
in the stock
83.3
83.3
66.7
66.7
83.3
83.3
66.7
66.7
83.3
83.3
83.3
83.3
75
75
83.3
83.3
83.3
83.3
75
75
0.391
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tween the PHCC was significant for all patient care indicators
except percentage of drugs adequately labeled and percentage
of patients’ knowledge of correct dosage (Table 1). Among
PHCCs, El-gomrok center represented the highest rank for
IRPCDU (Table 4 and Figure 2).
Facility-specific indicators
Percentage of copy of the EDL was 80 ± 42.2 and of key
drugs in the stock was 78.3 ± 7 (Table 2 and Figure 3).
Discussion
The irrational use of drugs occurs in all countries and causes
harm to people.13 In this study, WHO/INRUD drug use indi-
cators were basically used to: describe current treatment prac-
tices that are helpful for problem identification; identify
whether a facility is exceeding or under a set norm of
practice14; and be a baseline information for continuous mon-
itoring on an ongoing basis.
Prescribing indicators
Results of the present study revealed that the average number
of drugs per encounter was 2.5 ± .8 (Table 2). The difference
between PHCCs was statistically significant P= 0.000 (Ta-
ble 1). The optimal value of non-polypharmacy proposed in
this study was 63 drugs (Table 3). In a majority of developing
countries, this average number of drugs per encounter was
lower than that in this study and ranged between 1.3 and
2.2.15–18 In a study conducted at 13 PHC facilities in Kraguj-
evac, Serbia, this value ranged between 1 and 2.8.19 In village
clinics at rural Western China, this value was 2.4.20 In a study
conducted in 10 PHCC in Kingdom of Saudi Arabia (KSA),
the average was 2.4.21 Moreover, in a study conducted in the
Hawassa University Teaching and Referral hospital in south
Ethiopia, it was 1.9 ± .91.22
This means that PHC physicians have a tendency toward
prescribing only necessary medications. Rational prescribing
is advocated to avoid wastage of medicine and avoid possible
adverse effects in patients. Moreover, unnecessary medications
to patients have cost implications for national health systems.
The WHO highly recommends prescribing medication by
its generic name. It considers it as a safety precaution for
the patients as it gives clear identification and enables easy
information exchange and allows better communication be-
tween health care providers.23 Results showed that percent-
age of drugs prescribed by the generic name was 95.4
± 11.4 (Table 2). The difference between PHCCs was statis-
tically significant P= 0.000 (Table 1). The optimal value for
drugs prescribed by the generic name proposed in this study
was 100 (Table 3). The percentage of drugs prescribed by
the generic name is important as this makes information ex-
change and communication between health care providers
easier. In a majority of developing countries, this value
was >59%.15–18 In PHC facilities in Kragujevac, Serbia, it
was lower than 59%19, in rural clinics at Western China,
this value was 64.1,20 in KSA it was 61.2,21 and in a tertiary
care hospital in Ludhiana, India, it was very low (25%).24
However, results of the present study go hand in hand with
the results of the study conducted in south Ethiopia where
they were 98.7%.22
Results showed that percentage of encounters with antibiotic
prescribed was 39.2% (Table 2), and the difference between
PHCCs was statistically significant at P= 0.000 (Table 1). In
this situation, it is difficult to judge whether antibiotics were pre-
scribed irrationally as it may be due to a difference in the patient
population in terms of diseases. The optimal value proposed for
antibiotics prescribed in this study was 630 (Table 3). In devel-
oping countries, the percentage of encounters with antibiotics
prescribed had figures between 29%and 43%.15–18, in rural clin-
Table 2: WHO/INRUD drug use indicators at Alexandria
primary health care centers (2010).
WHO/INRUD drug use indicators PHCC
(1) Average drugs/encounter 2.5 ± .8
3
(2) % drugs prescribed by generic name 95.4 ± 11.4
100
(3) % encounters with an antibiotic prescribed 39.2 ± 8.8
0
(4) % encounters with an injection prescribed 9.9 ± .9
0
(5) % drugs prescribed from EDL/formulary 95.4 ± 11.4
100
(6) Average consultation time 7.1 ± 2.2
7
(7) Average dispensing time 47.4 ± 20
40
(8) % drugs actually dispensed 95.9 ± 10.9
100
(9) % drugs adequately labeled 0 ± 0
0
(10) Patients’ knowledge of correct dosage 94 ± 23.8
100
(11) % copy of EDL/formulary 80 ± 42.2
100
(12) % key drugs in the stock 78.3 ± 7
83.3
Table 3: Optimal levels of WHO/INRUD drug use indicators.
Indicators Optimal
level (%)
Optimal
index
Prescribing indicators
% non-Polypharmacy prescriptions 63 1
% drugs prescribed by generic name 100 1
% prescriptions including antibiotic 630 1
% prescriptions including injection 610 1
% drugs prescribed from EDL or formulary 100 1
Patient care indicators
% consultation time/min P30 1
% dispensing time/sec P60 1
% drugs actually dispensed 100 1
% drugs adequately labeled 100 1
% patients’ knowledge of correct dosage 100 1
Facility-specific indicators
% availability of copy of EDL or formulary 100 1
% availability of key drugs in the stock 100 1
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Table 4: Index rational drug use in primary health care centers across 8 districts of Alexandria, Egypt.
IRDU Smouha Sanstefano Eldeikhella Elaamreya Bor Elarab New Bor Elarab Baheig Elamrawy Elhaddara Elgomrok Elmafrouza
Prescribing indicators
(1) Index of non polypharmacy 1 1 1 0.97 1 1 0.94 1 1 1
(2) Index of generic name 0.97 0.99 0.95 0.89 0.96 0.96 0.98 0.95 0.95 0.94
(3) Index of rational antibiotic 0.75 0.77 0.71 1 0.55 1 0.57 0.79 0.7 1
(4) Index of safety injection 1 0.77 1 1 0.45 0.59 1 1 0.83 1
(5) Index of EDL 0.97 0.99 0.95 0.88 0.96 0.96 0.98 0.95 0.95 0.94
IRDP 4.69 4.52 4.61 4.74 3.92 4.51 4.47 4.69 4.43 4.88
Rank 3 5 4 2 9 6 7 3 8 1
Patient care indicators
(6) Consultation time index. 0.27 .25 .2 .21 .25 .27 .17 .2 .28 .26
(7) Dispensing time index 0.82 .71 .76 .89 .63 .85 .87 .67 .96 .74
(8) Dispensed drugs index 0.97 1 .91 .89 .97 .99 .95 .98 .98 .97
(9) Labeled drugs index 0 0 0 0 0 0 0 0 0 0
(10) Patients’ knowledge index 0.93 .97 .97 .93 .97 .9 .87 1 .97 .9
IRPCDU 2.99 2.93 2.84 2.92 2.82 3.01 2.86 2.85 3.19 2.87
Rank 3 4 9 5 10 2 7 8 1 6
Facility- specific indicators
(11) Index of EDL 1 1 1 0 1 1 0 1 1 1
(12) Index of key drugs in stock .83 .67 .83 .67 .83 .83 .75 .83 .83 .75
IRFSDU 1.83 1.67 1.83 .67 1.83 1.83 .75 1.83 1.83 1.75
Rank 1 3 1 5 1 1 4 1 1 2
Grand total
IRDU 9.51 9.12 9.28 8.33 8.57 9.35 8.08 9.37 8.45 9.5
Rank 1 6 5 9 7 4 10 3 8 2
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ics at Western China, this value was 48.4%,20 in KSA, it was
32.2%,21 and in the Hawassa University Teaching and Referral
hospital in south Ethiopia, it was 58.1%.22
Irrational use of antibiotics is a worldwide problem that
could lead to adverse reactions and hospital admission.25 So,
safety precautions should be taken when antibiotics are
Figure 1: Ranking Alexandria primary health care centers according to index rational drug prescribing.
Figure 2: Ranking Alexandria primary health care centers according to index rational patient care drug use.
Figure 3: Ranking Alexandria primary health care centers according to index rational facility specific drug use.
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prescribed.26 Overuse and misuse of antibiotics are a threat to
the health of populations.27 Over use of antibiotics results in
an increase of antibiotic resistance which is one of the prob-
lems under the irrational use of antibiotics.28
The present study revealed that the percentage of encounters
with injection prescribed was 9.9% (Table 2), and the difference
between PHCCs was significant at P= 0.000 (Table 1). In this
study, the percentage of encounters with injection prescribed
was lower than that of the study conducted at village clinics at
rural Western China (22.9%),20 in the study carried out at
PHC facilities in Kragujevac, Serbia, it ranged between 0%
and 25%,19 in KSA, it was 2%,21 and in south Ethiopia, it
was 38.1.22 The optimal value proposed for injection prescribed
in this study was 610% (Table 3). In a study conducted in Ye-
men, the optimal value proposed was 17.2%.17 An over use of
injections when oral medication can be more appropriate is an
irrational use of the medicine because the cost of an injection
is always higher than that of oral therapy.6 Moreover, blood-
borne diseases such as hepatitis andHIV/AIDS can be transmit-
ted by the use of non-sterile injections.29
The percentage of drugs prescribed from EDL/formulary
was 95.4% (Table 2), and the difference between PHCC was
significant at P= 0.000 (Table 1). This is comparable to re-
sults of a study conducted at village clinics of rural Western
China (67.7%),20 at PHC facilities in Kragujevac, Serbia
(<70%),19 and in a tertiary care hospital in Ludhiana, India
(66%).24 However, in developing countries, values were higher
than 80%.15–18,21,22 The optimal value proposed for the per-
centage of drugs prescribed from EDL/formulary in this study
was 100% (Table 3). Prescribing drugs from the EDL issued by
WHO means rational prescribing: drugs from the list are older
drugs, already tested in practice, with established clinical use,
and of lower cost than newer drugs.30
Patient care indicators
Results of the present study demonstrated that the average
consultation time was only 7.1 min (Table 2). The difference
between PHCCs was statistically significant at p= 0.000 (Ta-
ble 1). Such short consultation time corresponded well with
values measured in other developing countries (3–6.5 min).15–
18 It is also nearly similar to results of the study conducted
at PHC facilities in Kragujevac, Serbia (2.8–7 min),19 and in
a study conducted in 10 PHCC in KSA (7.3 min).31 The opin-
ion of WHO is that this time is too short to conduct a complete
patient evaluation and prescribe therapy.12 Short consultation
time reported in this study could be referred to a large number
of attendants/physician.
The optimal consultation time proposed in this study was
P30 min (Table 3). This time is considered to be sufficient to
conduct proper history taking – complete physical examina-
tion – appropriate health education instructions, and good
physician–patient interaction. This is important to ensure good
patient care.
Average dispensing time reported in this study was also
very short 47.4 s (Table 2). However, the proposed value was
P60 s (Table 3). The difference between PHCCs was signifi-
cant at P= 0.001 (Table 1). These times were considered long-
er than those reported in the study conducted at PHC facilities
in Kragujevac, Serbia (18.4–33 s),19 and in Nigeria (12.5 s).15–
18 Also, it was comparable to results reported in Nepal phar-
macies (86.1 s),32 and KSA (99.6 s).31 However, it was compa-
rable to the dispensing time reported in the tertiary care
hospital in Ludhiana, India (340 s).24 Short dispensing time
<60 s is not sufficient to explain dosage regimen, adverse ef-
fects of drugs, all precautions, and actually label and dispense
a drug. It is clear that patient compliance directly depends on
his/her knowledge about the drug. Prolongation of dispensing
time is a necessary step toward improving patient care.
The percentage of drugs actually dispensed was 95.9% (Ta-
ble 2). The difference between PHCCs was significant at
P= 0.000 (Table 1). This value is higher than that figured at
PHC facilities in Kragujevac, Serbia (39–68%).19 However, it
is nearly consistent with that reported at the tertiary care hospi-
tal in Ludhiana, India (100%).24 The optimal value proposed of
drugs actually dispensed in this study was 100% (Table 3). An
inadequate drug supply has its implications on patients’ health
status and patient’s convenience and trust in health system.
WHO recommends that each drug label should contain
dose regimen, patient name, and drug dose.1 In this study,
drug labeling practice was very poor at 0% (Table 2). This
attributes to lack of labeling system where dispensary person-
nel only write the frequency of administration of each drug on
the pillbox or medicines’ bag. Poor labeling reported in this
study is consistent with the results of the study conducted at
PHC facilities in Kragujevac, Serbia where patient’s name
was not written in the labels and dose regimen was not written
with all necessary details. In KSA, it represented 10%.31 How-
ever, all the dispensed drugs were adequately labeled in the ter-
tiary care hospital in Ludhiana, India.24 Omission of patient’s
name on the drug label is a serious matter, with potentially
serious consequences (drug misuse, and drug abuse).19
Patient’s knowledge of correct dosage was 94% (Table 2).
The optimal value proposed was 100% (Table 3). It was higher
than that reported in KSA (79.3%),31 and in the tertiary care
hospital in Ludhiana, India (46%).24 Patient’s knowledge of
correct dosage is highly beneficial to avoid drug over use and
abuse; and prevent adverse effects that harm patient’s health
status. A good patient’s knowledge of correct dosage will def-
initely improve patient care.
Facility indicators
Results revealed that two PHCCs had no copy of EDL/formu-
lary (Table 1) in comparison to the results reported in KSA
where only one center had no formulary.31 The optimal value
proposed for the percentage of EDL/formulary in this study
was 100% (Table 3). However, the percentage of key drugs
in the stock was 78.3 (Table 2). The optimal value proposed
for the percentage of key drugs in the stock in this study was
100%. (Table 3). Results of the present study are higher than
those of the study conducted at PHC facilities in Kragujevac,
Serbia where the percentage of key drugs in the stock was only
38.7%,19 and in KSA (59.2%).31 Shortage of the drug supply
of essential drugs that treat common health problems is harm-
ful to health status of patients. Moreover, this probably in-
creases the percentage of prescribing medicines out of the
stock. WHO recommends adherence of physicians to the drugs
listed in the EDL/formulary while prescribing medications to
ensure proper health care.
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Conclusion
This study measured the performance of PHCCs regarding the
use of drugs in Alexandria, Egypt using the WHO/INRUD
core drug use indicators. With respect to prescribing indica-
tors, results of the present study were less than the optimal va-
lue except that of average drugs/encounter and encounters
with injection prescribed. Concerning patient care indicators,
results were far from the optimal value especially for average
consultation time, drug labeling and average dispensing time.
With regard to facility specific indicators, results of this study
were also far from the optimal level.
Recommendations
(1) Motivating physicians working at PHCCs to prescribe
drugs by generic name.
(2) Motivating physicians to prolong consultation time that
allows them to take thorough history, examine patients
comprehensively, establish good rapport with patients
to improve patients care.
(3) Motivating dispensary personnel to explain drug regi-
men thoroughly to patients as this improves patients’
knowledge of correct dosage.
(4) Developing a labeling system and the drug label should
include: drug regimen, patient name, and drug dose.
(5) Improving the availability of key drugs in the PHCCs’
stocks to ensure treatment of common health problems.
(6) Future studies are needed to investigate the reasons
behind the irrational use of drugs as this could help solve
the problem.
(7) As this study is a baseline for measuring core drug use
indicators, further studies should be conducted for
ongoing monitoring and measuring patterns.
(8) WHO may play a role to encourage developing coun-
tries to enhance physicians/patients ratio.
Strength
A large sample size, 1000 prescriptions and 300 observations,
add strength to the work. Data collection from 10 centers
was a challenge. The use of WHO/INRUD core drug use indi-
cators and adherence to WHO methodology provides a lot of
strength to the study. Finally, developing indices to measure
the degree of rational/irrational drug use was important to
be reproduced for researchers.
Limitation
Results of this study could not reveal reasons that lead to irra-
tional use of drugs. Future studies are required to reveal these
reasons.
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